Carbon monoxide releasing molecule-2 increases fibrinogen-dependent coagulation kinetics but does not enhance prothrombin activity

Vance G Nielsen, S. Nini Malayaman, Ejaz S. Khan, James K. Kirklin, James F. George

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

We have previously determined that tricarbonyldichlororuthenium (II) dimer (CORM-2) increases plasma clot velocity of formation and strength by enhancing thrombin-fibrinogen interactions as determined by thrombelastography. The purpose of the present investigation was to further define the nature of CORM-2 interaction with prothrombin and fibrinogen by exposing purified proteins to CORM-2 or generating protein concentration-response curves in the absence or presence of CORM-2. Purified prothrombin was exposed to 0 or 100 μmol/l CORM-2 prior to being added to prothrombin-deficient plasma (n = 7-8 per condition). Fibrinogen-deficient plasma had fibrinogen added for a final concentration of 100-800 mg/dl and was exposed to 0 or 100 μmol/l CORM-2 (n = 4 per condition). Following tissue factor activation, thrombelastographic data were collected until clot strength stabilized. Exposure of prothrombin to CORM-2 did not significantly enhance coagulation kinetics. In sharp contrast, CORM-2 exposure enhanced fibrinogen coagulation kinetics in a concentration-dependent fashion, with peak effect seen at a fibrinogen concentration of 300 mg/dl that then progressively decreased throughout the range tested. Our data demonstrate that CORM-2 does not enhance plasma coagulation kinetics by modifying prothrombin; instead, the concept that CORM-2 modifies fibrinogen is the most likely explanation for the enhanced thrombin-fibrinogen interactions observed.

Original languageEnglish (US)
Pages (from-to)349-353
Number of pages5
JournalBlood Coagulation and Fibrinolysis
Volume21
Issue number4
DOIs
StatePublished - Jun 2010
Externally publishedYes

Fingerprint

Prothrombin
Carbon Monoxide
Fibrinogen
Thrombin
tricarbonyldichlororuthenium (II) dimer
Thrombelastography
Thromboplastin
Proteins

Keywords

  • Carbon monoxide releasing molecule
  • Fibrinogen
  • Prothrombin
  • Thrombelastography

ASJC Scopus subject areas

  • Hematology

Cite this

Carbon monoxide releasing molecule-2 increases fibrinogen-dependent coagulation kinetics but does not enhance prothrombin activity. / Nielsen, Vance G; Malayaman, S. Nini; Khan, Ejaz S.; Kirklin, James K.; George, James F.

In: Blood Coagulation and Fibrinolysis, Vol. 21, No. 4, 06.2010, p. 349-353.

Research output: Contribution to journalArticle

Nielsen, Vance G ; Malayaman, S. Nini ; Khan, Ejaz S. ; Kirklin, James K. ; George, James F. / Carbon monoxide releasing molecule-2 increases fibrinogen-dependent coagulation kinetics but does not enhance prothrombin activity. In: Blood Coagulation and Fibrinolysis. 2010 ; Vol. 21, No. 4. pp. 349-353.
@article{b06bdacbab96452d95aa70315b52ca27,
title = "Carbon monoxide releasing molecule-2 increases fibrinogen-dependent coagulation kinetics but does not enhance prothrombin activity",
abstract = "We have previously determined that tricarbonyldichlororuthenium (II) dimer (CORM-2) increases plasma clot velocity of formation and strength by enhancing thrombin-fibrinogen interactions as determined by thrombelastography. The purpose of the present investigation was to further define the nature of CORM-2 interaction with prothrombin and fibrinogen by exposing purified proteins to CORM-2 or generating protein concentration-response curves in the absence or presence of CORM-2. Purified prothrombin was exposed to 0 or 100 μmol/l CORM-2 prior to being added to prothrombin-deficient plasma (n = 7-8 per condition). Fibrinogen-deficient plasma had fibrinogen added for a final concentration of 100-800 mg/dl and was exposed to 0 or 100 μmol/l CORM-2 (n = 4 per condition). Following tissue factor activation, thrombelastographic data were collected until clot strength stabilized. Exposure of prothrombin to CORM-2 did not significantly enhance coagulation kinetics. In sharp contrast, CORM-2 exposure enhanced fibrinogen coagulation kinetics in a concentration-dependent fashion, with peak effect seen at a fibrinogen concentration of 300 mg/dl that then progressively decreased throughout the range tested. Our data demonstrate that CORM-2 does not enhance plasma coagulation kinetics by modifying prothrombin; instead, the concept that CORM-2 modifies fibrinogen is the most likely explanation for the enhanced thrombin-fibrinogen interactions observed.",
keywords = "Carbon monoxide releasing molecule, Fibrinogen, Prothrombin, Thrombelastography",
author = "Nielsen, {Vance G} and Malayaman, {S. Nini} and Khan, {Ejaz S.} and Kirklin, {James K.} and George, {James F.}",
year = "2010",
month = "6",
doi = "10.1097/MBC.0b013e328338948f",
language = "English (US)",
volume = "21",
pages = "349--353",
journal = "Blood Coagulation and Fibrinolysis",
issn = "0957-5235",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Carbon monoxide releasing molecule-2 increases fibrinogen-dependent coagulation kinetics but does not enhance prothrombin activity

AU - Nielsen, Vance G

AU - Malayaman, S. Nini

AU - Khan, Ejaz S.

AU - Kirklin, James K.

AU - George, James F.

PY - 2010/6

Y1 - 2010/6

N2 - We have previously determined that tricarbonyldichlororuthenium (II) dimer (CORM-2) increases plasma clot velocity of formation and strength by enhancing thrombin-fibrinogen interactions as determined by thrombelastography. The purpose of the present investigation was to further define the nature of CORM-2 interaction with prothrombin and fibrinogen by exposing purified proteins to CORM-2 or generating protein concentration-response curves in the absence or presence of CORM-2. Purified prothrombin was exposed to 0 or 100 μmol/l CORM-2 prior to being added to prothrombin-deficient plasma (n = 7-8 per condition). Fibrinogen-deficient plasma had fibrinogen added for a final concentration of 100-800 mg/dl and was exposed to 0 or 100 μmol/l CORM-2 (n = 4 per condition). Following tissue factor activation, thrombelastographic data were collected until clot strength stabilized. Exposure of prothrombin to CORM-2 did not significantly enhance coagulation kinetics. In sharp contrast, CORM-2 exposure enhanced fibrinogen coagulation kinetics in a concentration-dependent fashion, with peak effect seen at a fibrinogen concentration of 300 mg/dl that then progressively decreased throughout the range tested. Our data demonstrate that CORM-2 does not enhance plasma coagulation kinetics by modifying prothrombin; instead, the concept that CORM-2 modifies fibrinogen is the most likely explanation for the enhanced thrombin-fibrinogen interactions observed.

AB - We have previously determined that tricarbonyldichlororuthenium (II) dimer (CORM-2) increases plasma clot velocity of formation and strength by enhancing thrombin-fibrinogen interactions as determined by thrombelastography. The purpose of the present investigation was to further define the nature of CORM-2 interaction with prothrombin and fibrinogen by exposing purified proteins to CORM-2 or generating protein concentration-response curves in the absence or presence of CORM-2. Purified prothrombin was exposed to 0 or 100 μmol/l CORM-2 prior to being added to prothrombin-deficient plasma (n = 7-8 per condition). Fibrinogen-deficient plasma had fibrinogen added for a final concentration of 100-800 mg/dl and was exposed to 0 or 100 μmol/l CORM-2 (n = 4 per condition). Following tissue factor activation, thrombelastographic data were collected until clot strength stabilized. Exposure of prothrombin to CORM-2 did not significantly enhance coagulation kinetics. In sharp contrast, CORM-2 exposure enhanced fibrinogen coagulation kinetics in a concentration-dependent fashion, with peak effect seen at a fibrinogen concentration of 300 mg/dl that then progressively decreased throughout the range tested. Our data demonstrate that CORM-2 does not enhance plasma coagulation kinetics by modifying prothrombin; instead, the concept that CORM-2 modifies fibrinogen is the most likely explanation for the enhanced thrombin-fibrinogen interactions observed.

KW - Carbon monoxide releasing molecule

KW - Fibrinogen

KW - Prothrombin

KW - Thrombelastography

UR - http://www.scopus.com/inward/record.url?scp=77951902971&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77951902971&partnerID=8YFLogxK

U2 - 10.1097/MBC.0b013e328338948f

DO - 10.1097/MBC.0b013e328338948f

M3 - Article

VL - 21

SP - 349

EP - 353

JO - Blood Coagulation and Fibrinolysis

JF - Blood Coagulation and Fibrinolysis

SN - 0957-5235

IS - 4

ER -